These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 15984375
1. Cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: results of the HOLEM study. Harats D, Leibovitz E, Maislos M, Wolfovitz E, Chajek-Shaul T, Leitersdorf E, Gavish D, Gerber Y, Goldbourt U, HOLEM Study Group. Isr Med Assoc J; 2005 Jun; 7(6):355-9. PubMed ID: 15984375 [Abstract] [Full Text] [Related]
2. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Corrao G, Conti V, Merlino L, Catapano AL, Mancia G. Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788 [Abstract] [Full Text] [Related]
11. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl. Spencer FA, Goldberg RJ, Gore JM, Fox KA, Avezum A, Agnelli G, Kritharides L, Anderson FA, Goodman SG, FitzGerald G, Allegrone J, Brieger D, GRACE Investigators. Am J Cardiol; 2007 Sep 15; 100(6):913-8. PubMed ID: 17826369 [Abstract] [Full Text] [Related]
12. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S. Clin Ther; 2008 Jun 15; 30(6):1089-101. PubMed ID: 18640465 [Abstract] [Full Text] [Related]
16. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies. Glueck CJ, Aregawi D, Agloria M, Khalil Q, Winiarska M, Munjal J, Gogineni S, Wang P. Clin Ther; 2006 Jun 15; 28(6):933-42. PubMed ID: 16860175 [Abstract] [Full Text] [Related]
17. [Application of medical guidelines for the prescription of statins]. Chevalier C, Giral P, Chinaud F, Carzon M, Gartenlaub D, Blanchon B, Trutt B. Rev Epidemiol Sante Publique; 2002 Oct 15; 50(5):463-73. PubMed ID: 12471339 [Abstract] [Full Text] [Related]
18. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia. Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY. Clin Ther; 2005 Jul 15; 27(7):1074-82. PubMed ID: 16154486 [Abstract] [Full Text] [Related]
19. Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease. Lichtman JH, Amatruda J, Yaari S, Cheng S, Smith GL, Mattera JA, Roumanis SA, Wang Y, Radford MJ, Krumholz HM. Am Heart J; 2004 Mar 15; 147(3):522-8. PubMed ID: 14999204 [Abstract] [Full Text] [Related]
20. Achieving target cholesterol levels in diabetic patients: potency of the statin or potency of the physician? Shani M, Dresner J, Vinker S. Isr Med Assoc J; 2008 May 15; 10(5):354-7. PubMed ID: 18605358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]